Nubeqa (darolutamide) - Bayer, Orion Corp
Ac-225 rosopatamab tetraxetan (CONV01-α) - Dominari Holdings
Keytruda (pembrolizumab) - Merck (MSD)
https://cslide.ctimeetingtech.com/esmo2024/attendee/confcal_2/presentation
 
A. Holmes1; C. Thomas2; A.R. Fajardo3; M. Sun4; S. Huicochea Castellanos3; D.M. Nanus4; C.N. Sternberg4; A.M. Molina4; S. Yuan4; V. Avlonitis3; A. Patel5; P. Gregos6; J. Osborne7; N.H. Bander8; S.T. Tagawa4
 
Jul 19, 2024
 
Prev Next